Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomized, double-blind trial

Pain

Volumn 101, Issue 1-2, 2003, Pages 193-198

  Klepstad, Pal ^a   Kaasa, Stein ^b   Jystad, Åse ^a   Hval, Bjørn ^a   Borchgrevink, Petter C ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cancer; Immediate release morphine; Morphine; Pain; Start; Sustained release morphine

Indexed keywords

KETOGAN; MORPHINE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; AGED; ANALGESIA; APPETITE DISORDER; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; MALE; OPIOID INDUCED EMESIS; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SUSTAINED DRUG RELEASE; TITRIMETRY; VERTIGO;

EID: 0037223628     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00328-7     Document Type: Article

References (19)

1. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., Filiberti A., Fletchner H., Fleishman S.B., de Haes J.C.J.M., Kaasa S., Klee M., Osoba D., Razavi D., Rofe P.B., Schraub S., Sneeuw K., Sullivan M., Takeda F. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85:1993;365-376.
2. Broomhead A.F., Kerr R., Tester W., O'Meara P., Maccarone C., Bowles R., Hodsman P. Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain. J Pain Symptom Manage. 14:1997;63-73.
3. Campbell M.J., Julious S.A., Altman D.G. Estimating sample size for binary ordered categorical and continuous outcome in to group comparisons. Br Med J. 311:1995;1145-1148.
4. Cherny N.I., Coyle N., Foley K.M. Suffering in the advanced cancer patient: a definition and taxonomy. J Palliat Care. l0:1994;57-70.
5. Deschamps M., Band P.R., Hislop T.G., Rusthoven J., Iscoe N., Warr D. The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, cross-over study of immediate-release versus controlled-release morphine. J Pain Symptom Manage. 7:1992;384-392.
6. Morphine in cancer pain: modes of administration. Br Med J. 312:1996;823-826.
7. Fayers P., Aaronson N.K., Bjordal K., Sullivan M. EORTC QLQ-C30 Scoring Manual. 1995;EORTC Study Group on Quality of Life, Brussels.
8. Gourlay G.K., Cherry D.A., Onley M.M., Tordoff S.G., Conn D.A., Hood G.M., Plummer J.L. Pharmacokinetics and pharmacodynamics of twentyfour hourly Kapanol compared to twelve hourly MS Contin in the treatment of severe cancer pain. Pain. 69:1997;295-302.
9. Ferrel B.A. Pain management by elderly persons. Payne R., Pall R.B., Stratton Hill C. Assessment and Treatment of Cancer Pain. 1998;53-66 IASP Press, Seattle.
10. Hanks G.W., DeConno F., Cherny N., Hanna M., Kalso E., McQuay H.J., Mercadante S., Meynadier J., Poulain P., Ripamonti C., Radbruch L., Roca I., Casas J., Sawe J., Twycross R., Ventafridda V. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 84:200l;587-593.
11. Jacox A., Carr D.A., Payne R., Berde C.B., Breitbart W., Cain J.M., Chapman R.C., Cleeland C.S., Ferrel B.R., Finley R.S., Hester N.O., Hill C.S., Leak D.W., Lipman A.G., Logan C.L., McGarvey C.L., Miaskowski C.A., Stevenson Mulder D., Paice J.A., Shapiro B.S., Silberstein E.B., Stover J., Tsou C.V., Vecchiarelli L., Weissman D.E. Management of Cancer Pain: Adults Quick Reference Guide. No. 9. AHCPR Publication No. 9. AHCPR Publication No. 94-0593. 1994;Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service
12. Jadad A.R., Browman G.P. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. J Am Med Assoc. 274:1995;1870-1873.
13. Klepstad P., Kaasa S., Skauge M., Borchgrevink P.C. Pain intensity and side effects during titration of morphine to cancer patients using a scheduled fixed dose escalation. Acta Anaesthesiol Scand. 44:2000;656-664.
14. Klepstad P., Borchgrevink P.C., Kaasa S. Effects on cancer patients' health-related quality of life after the start of morphine therapy. J Pain Symptom Manage. 20:2000;19-26.
15. Radbruch L., Loick G., Schulzeck S., Beyer A., Lynch J., Stemmler M., Lindena G., Lehman K.A. Intravenous titration with morphine for severe cancer pain: report of 28 cases. Clin J Pain. 15:1999;173-178.
16. Salzman R.T., Roberts M.S., Wild J., Fabian C., Reder R.F., Goldenheim P.D. Can a controlled-release oral dose fonn of oxycodone be used as an immediate-release form for the purpose of titrating to stable pain control. J Pain Symptom Manage. 18:1999;271-279.
17. Schag C.C., Heinrich R.L., Ganz P.A. Karnofsky performance status revised: reliability validity and guidelines. J Clin Oncol. 2:1984;187-193.
18. Thirlwell M.P., Sloan P.A., Maroun J.A., Boos G.J., Besner J.-G., Stewart J.H., Mount B.M. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients. Cancer. 63:1989;2275-2283.
19. Vijayaram S., Ramamani P.V., Chandrashekhar S.N. Continuing care for cancer pain relief with oral morphine solution. Cancer. 66:1990;1590-1595.